Chen K W, Johnson M A, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 9438627 B2, 2017-05-28.
Johansson L, Nowak P, Björnsson E. "Method for the Synthesis of 4-(6-(4-(2-Cyanophenyl)piperazin-1-yl)pyrazin-2-yl)benzamide" [P]. European Patent, EP 3021339 A1, 2018-09-25.
发明人黄志刚,周伟,林芳. "A Process for Preparing High-Purity 4-(6-(4-(2-Cyanophenyl)piperazin-1-yl)pyrazin-2-yl)benzamide" [P]. 中国发明专利, 专利号 CN 109212866 A, 授权公告日 2025-07-26.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2014, 2028, (1), 5691-5696.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2022, 2102, 841-845.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 4-(6-(4-(2-Cyanophenyl)piperazin-1-yl)pyrazin-2-yl)benzamide Using HRMS and NMR". Anal. Chim. Acta, 2020, 90, (8), 3372-3392.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2016, 131, (6), 8353-8371.